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Abstract
Plants recognize microbes via specific pattern recognition receptors that are activated by microbe-associated molecular
patterns (MAMPs), resulting in MAMP-triggered immunity (MTI). Successful pathogens bypass MTI in genetically diverse
hosts via deployment of effectors (virulence factors) that inhibit MTI responses, leading to pathogen proliferation. Plant
pathogenic bacteria like Pseudomonas syringae utilize a type III secretion system to deliver effectors into cells. These
effectors can contribute to pathogen virulence or elicit disease resistance, depending upon the host plant genotype. In
disease resistant genotypes, intracellular immune receptors, typically belonging to the nucleotide binding leucine-rich
repeat family of proteins, perceive bacterial effector(s) and initiate downstream defense responses (effector triggered
immunity) that include the hypersensitive response, and transcriptional re-programming leading to various cellular outputs
that collectively halt pathogen growth. Nucleotide binding leucine-rich repeat sensors can be indirectly activated via
perturbation of a host protein acting as an effector target. AvrRpm1 is a P. syringae type III effector. Upon secretion into the
host cell, AvrRpm1 is acylated by host enzymes and directed to the plasma membrane, where it contributes to virulence.
This is correlated with phosphorylation of Arabidopsis RIN4 in vivo. RIN4 is a negative regulator of MAMP-triggered
immunity, and its modification in the presence of four diverse type III effectors, including AvrRpm1, likely enhances this RIN4
regulatory function. The RPM1 nucleotide binding leucine-rich repeat sensor perceives RIN4 perturbation in disease
resistant plants, leading to a successful immune response. Here, demonstrate that AvrRpm1 has a fold homologous to the
catalytic domain of poly(ADP-ribosyl) polymerase. Site-directed mutagenesis of each residue in the putative catalytic triad,
His63-Tyr122-Asp185 of AvrRpm1, results in loss of both AvrRpm1-dependent virulence and AvrRpm1-mediated activation
of RPM1, but, surprisingly, causes a gain of function: the ability to activate the RPS2 nucleotide binding leucine-rich repeat
sensor.
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Introduction
Pseudomonas syringae is a Gram-negative phytopathogen that
utilizes various biochemical means, including analogous enzymatic
activity or molecular mimicry of host proteins, to block or bypass
the plant immune system. To achieve this, each P. syringae strain
injects a suite of effector proteins into host cells using a type III
secretion system. The type III secretion system is shared by many
Gram-negative pathogens of plants and animals that use effector
proteins to subvert host cell physiology and bypass defenses [1–3].
Plants have evolved an elaborate intracellular detection system to
recognize effectors that attempt to block or dampen MAMP-
triggered immunity (MTI), and reinitiate the blocked immune
response [4]. Several well-studied nucleotide binding leucine-rich
repeat (NB-LRR)-dependent responses to effectors are mediated
by indirect recognition of effector action on a host target, as
described by the Guard Hypothesis [4,5]. In this model effector
targets functions as a molecular lure or ‘guardee’, and a specific
NB-LRR protein functions as a ‘guard’ [6–9]. Upon biochemical
manipulation of the guardee by an effector protein, the NB-LRR
protein is activated [4,5,10], leading to a successful immune
response. In the absence of the corresponding NB-LRR,
manipulation of the guardee can contribute to the virulence
activity of the effector [4,7].
This work focuses on the characterization of Pseudomonas syringae
type III effector protein AvrRpm1. AvrRpm1 function requires
consensus fatty acid acylation sites including the myristoylation site
of Gly2, likely followed by a subsequent palmitoylation site at Cys3
[11]. Once localized at the plasma membrane, AvrRpm1
associates with RIN4, and, by an unknown mechanism, triggers
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its phosphorylation [7]. RIN4 phosphorylation is presumed to
activate RPM1 and consequent downstream disease resistance
responses. This model has been experimentally validated for a
second, sequence diverse type III effector, AvrB, which targets the
same RIN4 sub-domain targeted by AvrRpm1 to activate RPM1
[12]. In the absence of RPM1, AvrRpm1 [13] and AvrB [14] can
contribute to overall pathogen virulence. Moreover, in the absence
of both RPM1 and RIN4, AvrRpm1 still contributes to virulence
[15], strongly suggesting that additional targets for AvrRpm1 exist
in Arabidopsis. Targeting of RIN4 by two additional P. syringae
effectors, AvrRpt2 [16–18] and HopF2 [9] suggest that RIN4 is a
point of convergence in the arms race between pathogen effectors
and critical host defense machinery [19].
Even though type III effectors are the main contributors to the
overall virulence of a phytopathogen, their diverse biochemical
functions in the host cell have only recently started to be dissected;
these include E3 protein ligase, phosphothreonine lyase, and ADP-
ribosyl transferase activities [20–23]. Determination of molecular
functions for type III effectors is complicated by their relatively low
conservation at the primary amino acid sequence level to proteins
of known biochemical function, suggesting convergent evolution
onto structures that modulate eukaryotic signaling pathways
[24,25]. Therefore, we used tertiary structure prediction in order
to gain insight into AvrRpm1 function. We found that AvrRpm1
consists of the fold from the catalytic domain of poly(ADP-
ribosyl)polymerase-1 (PARP-1).
PARPs belong to a large family of proteins that contain
additional domains beyond the canonical catalytic domain [26].
PARPs undergo self-modification by addition of ADP-ribose
moiety(s) from NAD or function analogously on other targets.
The addition of poly(ADP-ribose) (PAR) is reversible by poly(-
ADP-ribose) glycohydrolases (PARGs) [27]. Poly(ADP-ribose)
(PAR) can be toxic, often leading to inflammation, ischemia,
and eventually cell death in mammalian systems [28]. Nudix O-
acetyl-ADP-ribose hydrolases are responsible for the breakdown of
free PAR within the cell [29]. The Arabidopsis genome encodes
both PARGs and Nudix hydrolases, and both have been
implicated in immune responses [30,31]. More generally, ADP-
ribosylation of target proteins by toxins and type III effectors
results in the manipulation of host signaling and defense
machinery in both plant and animals, as evidenced by the
structurally related proteins Diphtheria toxin from Corynebacterium
diphtheriae, ExoS from Pseudomonas aeruginosa, and HopF2 from P.
syringae, and the structurally unrelated HopU1 [22,32–35].
We demonstrate that the AvrRpm1 family of type III effectors
shares the PARP catalytic fold, including key catalytic and
structural components of PARP such as the catalytic triad
H862-Y907-E998, which typically facilitates the ribosylation
reaction. We use mutagenesis and functional tests to demonstrate
that the conserved putative catalytic residues are required for
AvrRpm1 to either elicit an RPM1-dependent immune response
or contribute to virulence on a susceptible host. Furthermore, and
quite intriguingly, we show that putative catalytically inactive
AvrRpm1 inhibits the growth of P. syringae pathovar (pv.) maculicola
on disease susceptible plants. This growth inhibition is dependent
on activation of the NB-LRR protein RPS2. These findings
support previous work suggesting that over-expressed AvrRpm1
has an ‘off target’ ability to trigger an RPS2-mediated defense
response, and that RIN4 is not the only target for AvrRpm1
[15,36,37].
Despite our inability to demonstrate enzymatic activity, due to
inherent instability of purified AvrRpm1, our results collectively
support the hypothesis that AvrRpm1 is a PARP-type ADP-
ribosylating protein. Our data provide a starting point for
identification of a substrate for AvrRpm1 and for the definition
of how that substrate contributes to RIN4 phosphorylation and
inhibition of host defense. Our results also highlight the need for
further understanding of the complex relationship between RPM1,
RPS2, RIN4 and RIN-like proteins that may also be functionally
relevant in this system.
Materials and Methods
Creation of the Homology Models
The models were generated by querying the BioInfoBank
Institute’s metaserver where we initially were able to detect
homology with the catalytic domain of PARP-1. We compared
sequence alignments generated with ClustalX, using the programs
InSIGHTII, Accelrys Software Inc., and MODELLER [38–41].
We used PDB IDs: IUK0, IGS0, 1A26, and 3GJW as templates to
generate a structural map for which we could align the AvrRpm1
sequences. The model for the Psm allele was then evaluated for
fitness using the Verify 3D application in InSIGHTII.
Generation of AvrRpm1 mutants and P. syringae strains
Missense mutations for AvrRpm1 were generated by gene
splicing [42]. The external PCR primers are GatewayTM
compatible so that a common entry vector product could be used
for the generation of multiple destination vectors. Pto DC3000,
Psm CR299 carried the engineered missense mutations in trans on
the pDLTrp plasmid, a GatewayTM compatible derivative of the
pBBR1MCS vector [43] that uses a constitutively active trypto-
phan promoter. Missense alleles of AvrRpm1 were expressed in Pst
DC3000 as fusions to D79avrRpt2 as previously described [44]. An
avirulent P. fluorescens (Pf0) strain that has been engineered to carry
a stable integration of the hrp/hrc cluster as previously described
[45] was transformed with different combinations of the plasmids
pVSP61 carrying avrRpt2 [46,47] or the pDLTrp plasmid
mentioned above carrying either wild type avrRpm1 or the
missense mutations.
Electrolyte leakage, bacterial growth and translocation
assay conditions
Electrolyte leakage assay has been described [6] and modified to
include 4 leaf discs in 6 mL of water. Bacterial growth in leaves
was measured by inoculating 106 cfu/mL into the leaves of 4–5
week old plants. Leaf discs were extracted and ground in 10 mM
MgCl2 and serially diluted to measure bacterial numbers on the
day of infiltration as well as 3 days post infiltration (3 dpi).
ANOVA and a Tukey’s post-hoc analysis were performed on the
3pi data using the JMP H Genomics software suite, SAS Institute
Incorporated  2012 to determine if there was a statistically
significant difference among the growth levels of the various
strains. Bacterial growth in seedlings was measured by dip
inoculation as previously described [48]. Briefly, an inoculum of
105 cfu/mL was made for Pto DC3000 carrying either an empty
vector or avrRpm1 with missense mutations. Bacterial growth was
measured on the day of inoculation as well as 3pi. Translocation
assays were performed by inoculation of 4–5 week old plants with
56107 cfu/mL on one side of the leaf. Leaves were collected and
photographed 20 hpi.
Protein accumulation and immunoblot assay
For accumulation of proteins in plant tissue, leaf samples were
ground in extraction buffer containing 20 mM Tris pH 8.0,
150 mM NaCl,1% Triton X-100, 1 mM EDTA pH 8.0, 0.1%
SDS, 10 mM DTT Plant Protease Inhibitor Cocktail from Sigma-
Aldrich. Ground tissue was centrifuged for 20 minutes at 20,0006
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g. Supernatant was quantified by Bradford analysis, subjected to
SDS-PAGE and immunoblot analysis.
AvrRpm1/AvrRpt2 RIN4 competition assay
Pfo strains described in the methods section for generation of
AvrRpm1 mutants were infiltrated at 108 cfu/mL into 4-week-old
plants. Two leaves were collected for each time point and tissue
was harvested as described above. Extracts were subjected to
immunoblot analysis and probed with an a-RIN4 antibody
generated from a highly specific and antigenic peptide of RIN4.
Ribosylation Assay
Seedlings of either rpm1 or Dex::AvrRpm1-HA in rpm1 genotypes
were sparsely sown and grown on MS plates for 14 days [49]. The
seedlings were then sprayed with a solution of 25 mM dexameth-
asone (Sigma) and 25 nM biotinylated NAD (Trevigen). The
protein was extracted using the protocol described in the protein
accumulation and immunoblot assay methods. Duplicate prepa-
rations were made and one set was treated with phosphodiesterase
type I (Sigma) in 110 mM Tris pH 9.0, 110 mM NaCl and
15 mM MgCl2 [50]. The extracted protein was subjected to
immunoblot analysis and probed using pre-conjugated a-strepta-
vidin (Thermo). For agrobacterium-mediated transient ribosyla-
tion assay we followed the protocol established in [12]. We then
followed the protocol outlined above for labeling with biotinylated
NAD and phosphodiesterase type I treatment.
Results
Identification of conserved structural homology and a
putative PARP catalytic triad in AvrRpm1
We generated a computational homology model for AvrRpm1
to identify conserved structural domains shared with proteins of
known function. After removing the first 30 residues, which are
predicted to be disordered, we input the remaining AvrRpm1
amino acid sequence into the BioInfoBank Institute’s metaserver
[51]. The highest-ranking outputs for predicted homologous folds
from the aggregated databases were to various catalytic domains of
poly(ADP-ribosyl)polymerase (PARP) [26,52]. PARP is a member
of the larger family of Diphtheria toxin-like ADP-ribosyl
transferases [35,53,54]. The catalytic domain of these proteins
can be broken down into three regions (Figure 1A). The N-
terminal region 1 is a span of primarily conserved residues
highlighted by an aromatic residue (Figure 1A, denoted with W)
followed by the first catalytic triad member H63 (in AvrRpm1; all
residues noted refer to the allele from Psm M6, GEN BANK ID
AF359557.1 unless stated otherwise) and a glycine (G64). We also
noted the presence of a conserved leucine (L62) preceding this
region and a serine or threonine (T64) at its end in the majority of
the Diphtheria toxin-like ADP-ribosyl transferase proteins. The
centrally located region 2 is denoted by a pair of tyrosine residues
Y111 and Y122 separated by ten amino acids, where Y122
corresponds to the second member of the catalytic triad. The C-
terminal region 3 contains the third catalytic triad residue,
glutamate, or in the case of AvrRpm1 (Psm M6) aspartate
(D185). Mutation of the glutamate residue to an aspartate did not
abolish PARP-1 activity, but rather altered the in vitro kinetics [55].
The overall sequence identity between the catalytic domain of
PARP-1 and AvrRpm1 is relatively low, however these regions
and the relative spacing between them are conserved.
PARP-1 is a multi-domain protein [52], yet our homology
model demonstrates that conservation with AvrRpm1 is limited to
the catalytic domain. Hence, the model generated includes 70% of
AvrRpm1, but only 16% of PARP-1. Our model begins at residue
49 of AvrRpm1 and extends until residue 203. The validity of our
model was assessed using Verify3D, a program that compares the
model generated and its own amino acid sequence [56]. The
normalized average Verify3D score for the all residues in the
model was 0.26, with a typical score around 1.0 for crystal
structures and a typical score around 0.0 for incorrect folds. On
average, scores above 0.10 reflect models with some structural
validation. While there are loop regions that could not be
accurately modeled, it is important to note that the core fold is
predicted to be conserved between the two proteins (Figure 1B).
These loop regions and regions at the amino- and carboxy-
terminus of the model represent local minima in Verify3D score
while regions spanning the core fold represent local maxima in the
Verify 3D score and for these reasons we are confident in our
model build. Models were also generated for each of the remaining
AvrRpm1 family members: from P. syringae pvs. pisi race 6 (Ppi race
6), syringae B728a (Psy B728a), and phaseolicola 2708 (Psp 2708)
(AJ251482.1, [57], AAY35802.1 [58], and Ps pv. phaseolicola 2708
(unpublished) respectively) using the same PARP-1 templates
(PDB IDs: IUK0, IGS0, 1A26, 3GJW) [59–62]. The spacing
identified using the original metaserver output for the P. syringae
pv. maculicola AvrRpm1 allele, as well as an amino acid sequence
alignment for the four additional AvrRpm1 alleles (Figure S1), was
used to create the remaining models (Figure 1C–E).
The Psm M6 and Ppi race 6 AvrRpm1 alleles share the highest
identity, while the Psy B278a and Pph 2708 alleles are more
divergent. Each AvrRpm1 family member, except that from Psy
B728a, returned a structural match to either the PARP-1 catalytic
domain (Ppi) or to PARP-12 and -15, smaller isoforms belonging to
the PARP superfamily that contain only the catalytic domain (Pph
2708). We believe that the various programs aggregated in the
metaserver were unable to identify a similar match for the Psy
B728a allele due to a seven-residue deletion that occurs between
regions 2 and 3. This deletion alters the position of the third
putative catalytic triad residue (Figure 1A and S1).
Putative PARP catalytic triad residues are required for
activation of RPM1 by AvrRpm1
Identification of a putative catalytic triad (H63-Y122-D185;
Figure 1A) via homology modeling guided our introduction of
missense mutations and subsequent functional tests following
conjugation of mutant genes into Pto DC3000 (Methods). We
assayed each of the three missense mutations (H63A, Y122A,
D185A) for their ability to elicit AvrRpm1-dependent activation of
RPM1 as measured by cellular electrolyte leakage, a proxy for HR
cell death (Figure 2A). We found that each of the missense
mutations was compromised in their ability to trigger RPM1-
mediated HR, comparable to a previously characterized loss of
function, mislocalization mutant G2A [11]. We also assayed for
the ability of the missense mutations to trigger RPM1-dependent
growth restriction of Pto DC3000 in wild-type plants (Col-0) [63].
We found that Pto DC3000 carrying the missense mutations were,
surprisingly, unable to grow (Figure S2). One interpretation of this
result is that these missense alleles retain the ability to initiate
RPM1-dependent growth restriction, but not HR. However, data
subsequently presented complicate this overly simple conclusion,
and offer a clearer interpretation. To ensure that the AvrRpm1
missense alleles were not merely compromised in their ability to
traverse the type III secretion system, we cloned each loss of
function mutant as a fusion protein to truncated AvrRpt2 effector
protein lacking the N-terminal 79 amino acids required for its own
translocation [44]. These constructs were conjugated into Pto
DC3000 and infiltrated into leaves of plants lacking RPM1, but
expressing functional RPS2. These fusion effector proteins thus
AvrRpm1 Missense Mutations Activate RPS2
PLoS ONE | www.plosone.org 3 August 2012 | Volume 7 | Issue 8 | e42633
AvrRpm1 Missense Mutations Activate RPS2
PLoS ONE | www.plosone.org 4 August 2012 | Volume 7 | Issue 8 | e42633
rely on the native type III secretion signals from AvrRpm1 for
delivery into the host cell, but on the activity of D79AvrRpt2 to
initiate RPS2-dependent HR. Each of the missense mutations was
translocated via the type III secretion system (Figure 2B), an
indication that the proteins are both expressed and stably
accumulate to levels necessary for delivery into the host.
Putative PARP catalytic triad residues are required for the
virulence function of AvrRpm1
Each AvrRpm1 missense mutation was tested for its virulence
[13]. AvrRpm1 missense mutations were expressed in P. syringae pv
maculicola (Psm) strain M2 CR299, which carries an insertion in
avrRpm1 that disables this gene (CR299; [13]) (Figure 3A). Psm M2
CR299 carrying a wild type copy of avrRpm1 in trans grew at least
ten-fold more than either Psm M2 CR299, or an isogenic strain
that can deliver the mislocalized AvrRpm1 G2A missense mutant
[11]. Each of the putative AvrRpm1 catalytic triad missense
mutations was also compromised for virulence mediated by
AvrRpm1. In fact, the expression of these putative catalytic triad
mutants inhibited the growth of Psm M2 CR299 to a higher extent
with respect to CR299 or to CR299 complemented with the
localization AvrRpm1G2A mutant (Figure 3A). To determine if
plasma membrane localization was required for this surprising
phenotype, we tested the virulence activity of an AvrRpm1 double
mutant in both the putative catalytic activity and localization/
Figure 1. AvrRpm1 exhibits structural homology to the catalytic domain of Poly-ADP-ribosyl polymerase (PARP). (A) Sequence
alignment of DT family ADP-ribosylating proteins [35] and the four AvrRpm1 family proteins illustrating key regions of conservation. Secondary
structure for each region is shown above. Highly conserved residues are highlighted in blue. Red carets denote the catalytic triad of PARP. (B)
Homology model of the AvrRpm1 reference allele (copper) from P. syringae pv. maculicola M6 (Psm M6) with the catalytic domain of Poly-ADP-ribosyl
polymerase 1 (PARP-1; PDB ID: 3GJW) (silver). The side chains for residues highlighted in (A) are denoted by dark blue (AvrRpm1) and light blue
(PARP-1). Residues in the catalytic triad are labeled according to AvrRpm1. ‘‘N’’ and ‘‘C’’ represent the amino- and carboxy-terminus of the protein
respectively. Independent homology models for the remaining three AvrRpm1 family members from (B) P. syringae pvs. syringae B728a (Psy B728a),
(C), pisi race 6 (Ppi race 6) (D), and phaseolicola 2708 (Psp 2708).
doi:10.1371/journal.pone.0042633.g001
Figure 2. Missense mutants of AvrRpm1 do not elicit an RPM1-mediated hypersensitive response, but can be translocated. (A) Four
week old Col-0 plants were hand inoculated with 56107 cfu/mL Pto DC3000 carrying either an empty vector or avrRpm1 with missense mutations
eliminating localization to the membrane (G2A) [11], to the putative catalytic triad (H63A, Y122A, and D185A) and a double mutant (G2A D185A) and
assayed for the ability to promote electrolyte leakage via RPM1-mediated hypersensitive response (HR) (see Methods). Error bars represent 26SEM.
(B) Five week old rpm1 RPS2 plants were infiltrated with 56107 cfu/mL Pto DC3000 carrying missense mutations of avrRpm1 cloned to produce fusion
proteins with D79avrRpt2. The ability to elicit an RPS2-mediated hypersensitive response was assayed at 20 hours post inoculation (HPI). Leaf counts
(HR positive/total inoculated) are displayed under representative leaves.
doi:10.1371/journal.pone.0042633.g002
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myristoylation (AvrRpm1G2A D185A). We found that this strain
grew to levels equal to Psm M2 CR299 expressing the mislocalized
missense mutation G2A (Figure S3). These data suggest that the
missense mutations must be properly localized inside the host cell
in order to inhibit the growth of Psm M2 CR299.
Missense mutations of AvrRpm1 proteins are perceived
by the NB-LRR protein RPS2
Given the surprising result that Psm M2 CR299 strains
expressing missense alleles in the putative catalytic triad of
AvrRpm1 grew significantly less on susceptible rpm1 hosts than
controls, we wanted to investigate the mechanism responsible for
this effect. We generated two plausible hypotheses (1)
AvrRpm1D185A binds its nominal target, or a new target, in an
altered manner, causing sufficient target perturbation to activate
an NB-LRR protein other than RPM1 to fire at low levels that are
sufficient to limit pathogen growth; (2) AvrRpm1D185A is able to
bind its nominal target, or a new target, in a manner that
sequesters this target from other type III effector proteins delivered
by Psm M2 CR299, preventing them from effectively contributing
to that strain’s virulence. We assayed the ability of Psm M2
CR299-derived strains carrying the AvrRpm1 missense alleles to
grow on plants that are null for both the RPM1 and RPS2 NB-
LRR disease resistance proteins (rpm1 rps2), because RPS2 is an
explicit candidate for weak recognition of AvrRpm1 [36]. In fact,
Psm M2 CR299 expressing AvrRpm1D185A grew as well as the loss
of function mislocalization allele, AvrRpm1G2A in leaves of rpm1
rps2. Thus, the ability of AvrRpm1D185A expression to inhibit the
growth of Psm M2 CR299 is due to weak activation of RPS2 that is
insufficient to trigger macroscopic HR (Figure 2A and 3B). We
observed the same growth patterns of Psm M2 CR299 expressing
the AvrRpm1 missense alleles on susceptible rpm1 rps2 rin4 plants
(Figure 3C). Each of the AvrRpm1 missense mutations used in this
assay accumulated normally in P. syringae (Figure 3D) and, as noted
above, was translocated (Figure 2B). Together, these results
demonstrate that the ability of the AvrRpm1D185A to restrict
growth of an otherwise virulent pathogen is dependent on its
myristoylation and localization at the plasma membrane, and its
‘off-target’ perception there by RPS2.
Missense alleles of AvrRpm1 do not show increased
interference with AvrRpt2 cysteine protease activity on
RIN4
The type III effector AvrRpt2 functions as a cysteine protease
that directly interacts with RIN4, cleaving it at N- and C-terminal
RCS (RIN4 cleavage sites) resulting in rapid degradation of the
remaining RIN4 fragments [17,18,64]. One hypothesis to explain
the results reported above is that AvrRpm1 prevents binding and
cleavage of RIN4, or a RIN4-like substrate, by AvrRpt2. In this
model, this blockade of the proposed substrate’s ability to interact
appropriately with RPS2 would lead to ectopic RPS2 activation in
the same manner that RIN4 is genetically required to negatively
Figure 3. Putative catalytic triad residues are required for
AvrRpm1 virulence that is inhibited via weak activation of
RPS2-mediated disease resistance. (A–C) Growth of Psm CR299, a
derivative of Psm M2 that carries an insertion in avrRpm1 [13] was
complemented in trans with plasmids expressing wild type AvrRpm1
and missense mutations as noted. Four week old rpm1 (A), rpm1 rps2
(B) or rpm1 rps2 rin4 (C) plants were inoculated with 106 cfu/mL and
samples were collected on day 0 and day 3. Error bars represent 26
SEM. An analysis of variance (ANOVA) was performed among the day 3
samples followed by Tukey’s post-hoc analysis (a= 0.05) with signifi-
cance groups indicated by letters on the graph. (D) Immunoblot assay
for accumulation of the wild type and mutant AvrRpm1 proteins at 3
days post inoculation for strains used in (B) and (C).
doi:10.1371/journal.pone.0042633.g003
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regulate an otherwise lethal activation of RPS2 [6,15]. Thus,
AvrRpm1 and its missense alleles were tested for their ability to
directly inhibit the ability of AvrRpt2 to cleave RIN4. Each
AvrRpm1 missense mutation was expressed in trans together with
AvrRpt2 in Pseudomonas fluorescens, a non-pathogen engineered to
carry a competent type III secretion apparatus [45]. The ability of
AvrRpt2 to cleave RIN4 leading to the overall disappearance of
RIN4 over time was assayed via western blot analysis using native
RIN4 antisera (Figure S4). Neither wild type AvrRpm1 nor the
missense alleles consistently inhibited the cleavage and clearance
of RIN4 by AvrRpt2 by 6 hours post-infection (Figure 4),
consistent with the lack of effect of RIN4 on the growth
suppression phenotype displayed by the AvrRpm1 missense
alleles. However, we reproducibly detected attenuation of cleavage
and clearance of RIN4 by AvrRpt2 in the presence of wild type
AvrRpm1, mislocalized AvrRpm1G2A or the putative non-
functional AvrRpm1D185A. The double mutant AvrRpm1G2A
D185A reproducibly lacked this ability. We speculate that this
attenuation is due to weak inhibitory activity of mislocalized, but
functional, AvrRpm1G2A on RIN4 [11], and a similar inhibitory
activity of properly localized, but non-functional, AvrRpm1D185A
on RIN4. The lack of attenuation of RIN4 cleavage by AvrRpt2
observed for AvrRpm1G2A D185A can be explained by the
combined loss of function of the two single mutants. In sum these
data do not eliminate the possibility that the AvrRpm1 missense
alleles exhibit their novel phenotype via binding to another RIN4-
related target more tightly than does the wild type AvrRpm1,
leading to a previously undefined activation of RPS2 and
subsequent pathogen growth suppression.
AvrRpm1 may function as a molecular mimic of ADP-
ribosyl transferases
We have tried to ascertain whether AvrRpm1 functions as an
ADP-ribosyl transferase using established assays [22]. However,
we were unable to successfully purify AvrRpm1 to homogeneity as
a soluble and folded protein. We tested the ability of AvrRpm1 to
catalyze a ribosyl-transferase reaction using biotinylated nicotin-
amide adenine dinucleotide (NAD) as a substrate in a dexameth-
asone inducible transgenic plant line expressing AvrRpm1, and
found that there appears to be no alteration in ribosylation state
due to the presence of AvrRpm1 (Figure S5). To confirm that we
were indeed assaying for ribosylation we treated duplicate cellular
extracts with phosphodiesterase, which cleaves the ester bond in
the ADP-ribose moiety, freeing the biotin label (Figure S5A). This
ribosylated band appears to be of the same molecular weight as the
endogenously ribosylated protein identified by Wang et al. in April
2011 [65]. We also tested for direct activity on RIN4, as well as
any alteration in ribosylation signatures between wild type
AvrRpm1 and D185A using a transient expression system in N.
benthamiana [12], but again observed only what appeared to be an
endogenous ribosylation event (Figure S5C). In the absence of
additional functional tests, it also remains plausible that AvrRpm1
functions as a molecular mimic of an ADP-ribosyl transferase, and
blocks that enzyme’s function.
Discussion
We demonstrate that the type III effector protein AvrRpm1
displays a homologous fold to ADP-ribosyl transferases (Figure 1A
and B). This homology extends to residues (H63-Y122-D185) that
are required for both AvrRpm1 virulence and recognition of
AvrRpm1 by the NB-LRR protein RPM1 (Figure 2A). Mutation
of the putative catalytic residue D185 results in a unique loss of
virulence phenotype on susceptible plants; this phenotype is
suppressed when this protein is mislocalized (Figures 3A and S3).
This phenotype reflects the recognition of AvrRpm1D185A by the
NB-LRR protein RPS2 (Figure 3B). Additionally, this phenotype
is not altered by the absence of RIN4 (Figure 3C) and the missense
alleles do not contribute to an increase in interference with
AvrRpt2 cleavage of RIN4 (Figure 4).
The poly(ADP-ribosyl)ation reaction in mammalian systems is
involved in stress signaling, chromatin modulation, transcriptional
regulation, proteasome activation and cell death [28]. ADP-
ribosylation is employed by microbes to manipulate eukaryotic
host cell signaling machinery. Diphtheria toxin from Corynebacte-
rium diphtheriae and ExoS from Pseudomonas aeruginosa are virulence
effectors for pathogens of mammals that target elongation factor 2
(eEF-2) and Ras GTPase, respectively [53].
There is growing evidence that ADP-ribosylation plays a critical
role in phytopathogenicity as well as in plant immune responses.
While no biochemical function has been attributed to P. syringae
AvrPphF/HopF1, this effector adopts a fold similar to members of
the Diphtheria toxin family of ADP-ribosyl transferases. Missense
mutation of the catalytic histidine and glutamate residues led to
both loss of the ability to trigger efficient disease resistance on
resistant bean cultivars, and a decrease in pathogen growth on
susceptible bean cultivars [66], analogous to our findings. Despite
the inability to assign a biochemical function to HopF1, the
homologous type III effector HopF2 has been shown to possess
ADP-ribosylation activity on MAP kinase kinase 5, leading to
inhibition of MTI [22]. Additionally HopU1, which is structurally
Figure 4. AvrRpm1 mutants do not exhibit increased interfer-
ence with AvrRpt2-mediated cleavage of RIN4. Pfo expressing
wild type AvrRpt2 and either wild type or AvrRpm1 missense mutations
in trans was infiltrated into leaves of 4-week-old rpm1 rps2 plants at
108 cfu/mL. Samples were collected over a time course (as indicated)
and probed for the presence of RIN4 as an output of AvrRpt2 function.
doi:10.1371/journal.pone.0042633.g004
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similar the Cholera toxin family, is able to catalyze the addition of
ADP-ribose onto the glycine rich RNA-binding protein GRP7, a
component of plant innate immunity [20,33].
Beyond direct targeting of ADP-ribosyl transferase toxins to
host substrates, it appears that the host ADP-ribosyl transferase
pathway itself is activated during immune response: genes
encoding both PARG and Nudix hydrolases are up-regulated in
the presence of MAMPs, in particular the flagellar peptide-flg22
[30]. Given these host responses to MAMPs, it is plausible that
non-functional ADP-ribosyl transferase proteins could also inter-
fere with wild type cellular outputs, as we postulate may occur for
AvrRpm1. Hence, our results coincide with the increasing
evidence that the ADP-ribosylation pathway plays a critical role
in the interplay between phytopathogen and host.
AvrRpm1 appears to function as a molecular mimic of ADP-
ribosyl transferases; whether it has enzymatic activity remains
unknown. We could not determine a biochemical function for
AvrRpm1, despite our demonstrated genetic requirement for
intact residues analogous to those forming the PARP catalytic
triad. We attempted to purify both wild type AvrRpm1 and
AvrRpm1D185A, as well as the most divergent allele P. syringae pv.
phaseolicola 2708 from various sources. In all cases, the homogenous
protein we recovered did not maintain folded conformation. To
side-step these challenges, we utilized transgenic plant lines
conditionally expressing AvrRpm1 and modified the ADP-
ribosylation assays presented in Wang et al. [22] to define its
biochemical function and potential substrate(s). However, we did
not observe increased ADP-ribosylation compared to background
levels (Figure S5). Additionally the band that is ADP-ribosylated in
this assay is approximately the same size as a band that was
identified previously as an endogenously ADP-ribosylated protein
in Arabidopsis [65]. We cannot rule out that our current assays are
below detection threshold for identification of AvrRpm1 ADP-
ribosylation activity. Additionally, the transient nature of the
reaction and its reversal by PARG may interfere with accurately
capturing targets in a whole cell context. Further work will need to
be done on isolation of AvrRpm1 and identification of target
proteins so that direct biochemical analysis may be performed.
Chisholm et al. [16] proposed that AvrRpm1 evolved to block
RIN4-mediated MAMP defenses, and that this led to the evolution
of RPM1. In their model, AvrRpt2 evolved to overcome
AvrRpm1-dependent activation of RPM1, and RPS2 evolved to
prohibit its function. Both RPM1 and RPS2 demonstrably
monitor the integrity of RIN4 [6,7,15]. However, the work
presented above and previous findings show (1) that RIN4 is
dispensable for AvrRpm1 and AvrRpt2 virulence function [15,37];
(2) that both RPM1 and RPS2 can be activated by over-expression
of wild type AvrRpm1 [7,36]; and (3) that AvrRpm1 and AvrRpt2
are, to date, never found in the same strain [6,7,13,15,36,64,67].
Importantly, Kim et al. [36] demonstrated that over-expression
of AvrRpm1 can activate RPS2 in rpm1 plants; this activation was
not directly attributed to an alteration in the phosphorylation state
of RIN4. They hypothesized that what were once believed to be
phenotypic cytotoxic indicators of ‘effector virulence activities’ are
actually the phenotypes of weak ETI [36]. Our work supports this
finding, in that RPS2 is activated by the putatively catalytic
missense allele AvrRpm1D185A delivered at near wild type levels
from P. syringae or P. flourescens.
This surprising result could be due to several factors. First,
AvrRpm1 is likely to have multiple homologous targets within the
host [15], as with AvrPto and AvrPphB targeting multiple receptor
kinases and receptor-like kinases [68,69], or AvrRpm1 may target
multiple unrelated proteins analogous to HopF2’s activity on both
RIN4 and MEKK5 [9,22]. Second, AvrRpm1D185A could either
bind more tightly to, or be less able to release from, an RPS2-
associated target protein than the wild type AvrRpm1. Our results
reinforce the evidence that RIN4 is not the only AvrRpm1 target
in Arabidopsis [15,70], and re-focus attention onto the other ten
members of the RIN4-like NOI-domain containing proteins in
Arabidopsis [18,64]. RPS2 exists in a lipid raft with other
components that contribute to immune signaling, potentially
including RPM1 and the flagellin receptor FLS2, and can be cross
linked to these components [71]. Thus, there exists the intriguing
possibility that RPS2 can also monitor perturbation of alternative
target(s). Experimental analysis of this idea is difficult, since rin4
mutation is lethal in the presence of RPS2 [6]. Immune signaling
in Arabidopsis may thus function like ‘‘bells on a string’’- when one
part of the signaling complex gets perturbed the rest makes a
sound with the amplitude and relative ‘‘pitch’’ modified by the
composition of the signaling complex, even in the absence of what
was previously believed to be the major component, as we
observed for weak activation of RPS2 in the absence of RPM1.
Supporting Information
Figure S1 Alignment of AvrRpm1 alleles. Alignment of
AvrRpm1 alleles generated with ClustalX. Conserved regions
between PARP and AvrRpm1 are highlighted in light blue.
(TIF)
Figure S2 Pto DC3000 expressing AvrRpm1 missense
mutations cannot grow on wild type plants. Two week old
Col-0 seedlings were dipped into an inoculum with 105 cfu/mL
Pto DC3000 carrying either an empty vector or avrRpm1 with
missense mutations eliminating localization to the membrane
(G2A) [11], or in putative catalytic triad (Y122A and D185A) and
a double mutant (G2A D185A). Samples were assayed for
bacterial growth on day 0 and day 3. Error bars represent 26
SEM.
(TIF)
Figure S3 A mislocalized AvrRpm1 double mutant, G2A
D185A does not limit virulence. Growth of Psm CR299
(carrying an insertion in avrRpm1) was complemented in trans with
avrRpm1 and the indicated missense mutations. Leaves of 4-week-
old rpm1 plants were inoculated with 106 cfu/mL and samples
were collected on day 0 and day 3. Error bars represent 26SEM.
An analysis of variance (ANOVA) was performed among the day 3
samples followed by Tukey’s post-hoc analysis (a= 0.05) with
significance groups indicated by letters on the graph.
(TIF)
Figure S4 Generation of new antibody using RIN4
specific peptide. New antibody against RIN4 was generated
against peptide from amino acids 57 to 69 (PSSRTKPEQVDTV)
based on high antigenicity and sequence uniqueness. Immunoblot
analysis was performed on wild type (Col-0) and plants lacking
RIN4 protein (rpm1 rps2 rin4).
(TIF)
Figure S5 AvrRpm1 does not preferentially ribosylate
Arabidopsis proteins, or RIN4. (A) Two week old seedlings
were sprayed with a solution of 25 mM dexamethasone and
25 nM biotinylated NAD. Seedlings were collected 12 hours later
and a duplicate sample was treated with PDE type I to remove the
ribosylation modification. Samples were then subjected to
immunoblot analysis with a-streptavidin antibody. (B) Replicate
samples as in (A) subjected to immunoblot analysis a-HA antibody
for expression of AvrRpm1-HA. (C) N. benthamiana was left un-
infiltrated or was infiltrated with A. tumefaciens carrying RIN4 and
either estradiol inducible AvrRpm1-HA or AvrRpm1D185A-HA.
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Upon induction of AvrRpm1 expression, leaves were also treated
with biotinylated NAD and six hours later samples were collected
and subjected to immunoblot analysis. Figure shows expected
apparent molecular weight range for RIN4 (23 kDa). (D)
Replicate samples as in part (C) subjected to immunoblot analysis
a-HA antibody for expression of AvrRpm1WT and
AvrRpm1D185A and a-T7 antibody for expression of RIN4.
(TIF)
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